Delivery Order SPE2DB22D2218-SPE2DB25FR2WQ
Award Date 6/30/25
Potential Completion Date 7/22/25
Potential Value $9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $8,954.00 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HYPERRAB 300 UNIT/ML VIAL 5ML, a pharmaceutical product, with a period of performance through July 15, 2025. The contract is not set-aside and was competitively awarded. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery...
- This is a $7,268.75 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HYPERRAB 300 UNIT/ML VIALML, a pharmaceutical product, with a period of performance through July 24, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HYPERRAB 300 UNIT/ML VIAL 5ML, a pharmaceutical product. The contract is a firm fixed price delivery order with a ceiling value of $7,163.24 and a period of performance through June 13, 2025. The contract is not set aside for any special program. Amerisourcebergen Drug Corp holds a...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,744.80, is for the delivery of HYPERRAB 300 UNIT/ML VIAL 5ML medical supplies. The contract is not set-aside and has an ultimate completion date of June 25, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HYPERRAB 300 UNIT/ML VIAL 5ML, a medical product, with a ceiling value of $7,163.24 and a period of performance through July 31, 2025. The contract is not set aside and was awarded on July 10, 2025. Amerisourcebergen Drug Corp is a for-profit organization...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HYPERRAB 300 UNIT/ML VIAL 5ML, a medical product, with a ceiling value of $17,908.00. The contract is a firm fixed-price delivery order with a completion date of July 30, 2025. This award is not set aside and is part of a larger Indefinite Delivery Contract (IDC) valued at...
- This is a $18,609.00 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HYPERRAB 300UNIT/ML 1S medical supplies, with a period of performance through April 10, 2024. This contract award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical,...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is for the delivery of HYPERRAB 300 UNIT/ML VIAL 3ML, a pharmaceutical product, with a ceiling value of $6,616.74 and a period of performance ending on July 10, 2025. This contract is not set-aside and was awarded on June 17, 2025. Amerisourcebergen...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HYPERRAB 300 UNIT/ML VIAL 5ML, a pharmaceutical product. The contract has a firm fixed price of $10,744.80 and a completion date of June 3, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite...
- This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $10,744.80, is for the procurement of HYPERRAB 300 UNIT/ML VIAL 5ML, a medical product. The contract has a period of performance through February 25, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...